Hi Jonty,
Study results utilizing OBJ's DP technology to deliver naltrexone through excised human epidermis fluxed 95 times over passive diffusion which very successfully showed proof of concept for this delivery system to be significantly more effective than the normal oral method of delivery.
The following study result details provide a better understanding:
Click here for in vivo study results of Naltrexone
Click here for a "Shareholder Update" which was presented Dec 2008
Click here for a "Technology Testing Update" which was presented on April 6 2009
learn to play the game., page-19
Add WFL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable